Skip to main content

Advertisement

SpringerLink
Log in

Levo-Tetrahydropalmatine Retards the Growth of Ectopic Endometrial Implants and Alleviates Generalized Hyperalgesia in Experimentally Induced Endometriosis in Rats

  • Original Articles
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

One primary goal of medical treatment of endometriosis is to alleviate pain and there is a pressing need for new therapeutics for endometriosis with better efficacy and side-effect profiles. Levo-tetrahydropalmatine (l-THP) has been used as a sedative or analgesic for chronic pains in China since 1970s. In this study, we sought to evaluate the efficacy of l-THP, with or without valproic acid (VPA), in a rat model of endometriosis. We surgically induced endometriosis in 55 adult female rats. Two weeks after, all rats were further divided into 5 groups randomly: untreated, low- and high-dose of l-THP, VPA, and l-THP + VPA. Response latency in hotplate test was measured before the surgery, before and after 3-week treatment of respective drugs. All rats were then sacrificed for analysis. The average lesion size and the immunoreactivity to N-methyl-d-asparate receptor 1 (NMDAR1), acid-sensing ion channel 3 (ASIC3), calcitonin gene-related peptide (CGRP), c-Fos, tyrosine kinase receptor A (TrkA), and histone deacetylase 2 (HDAC2) in dorsal root ganglia (DRG), to phorphorylated p65, HDAC2, TrkA, and CGRP in ectopic endometrium and to phorphorylated p65 and CGRP in eutopic endometrium were evaluated. We found that rats receiving l-THP, with or without VPA, had significantly reduced lesion size and exhibited significantly improved response to noxious thermal stimulus. The treatment also significantly lowered immunoreactivity to all mediators involved in central sensitization and to HDAC2 in DRG, to TrkA and CGRP in ectopic endometrium, and to CGRP in eutopic endometrium. In summary, l-THP reduces lesion growth and generalized hyperalgesia. Thus, l-THP may be a promising therapeutics for endometriosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Olive DL, Lindheim SR, Pritts EA. New medical treatments for endometriosis. Best Pract Res Clin Obstet Gynaecol. 2004;18(2):319–328.

    Article  PubMed  Google Scholar 

  2. Giudice LC, Kao LC. Endometriosis. Lancet. 2004;364(9447):1789–1799.

    Article  PubMed  Google Scholar 

  3. Wheeler JM, Malinak LR. Recurrent endometriosis: incidence, management, and prognosis. Am J Obstet Gynecol. 1983;146(3):247–253.

    Article  CAS  PubMed  Google Scholar 

  4. Waller KG, Shaw RW. Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up. Fertil Steril. 1993;59(3):511–515.

    Article  CAS  PubMed  Google Scholar 

  5. Kiilholma P, Tuimala R, Kivinen S, Korhonen M, Hagman E. Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis. Fertil Steril. 1995;64(5):903–908.

    Article  CAS  PubMed  Google Scholar 

  6. Lessey BA. Medical management of endometriosis and infertility. Fertil Steril. 2000;73(6):1089–1096.

    Article  CAS  PubMed  Google Scholar 

  7. Bulun SE, Lin Z, Imir G, et al. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev. 2005;57(3):359–383.

    Article  CAS  PubMed  Google Scholar 

  8. Nothnick WB, D’Hooghe TM. Medical management of endometriosis: novel targets and approaches towards the development of future treatment regimes. Gynecol Obstet Invest. 2003;55(4):189–198.

    Article  PubMed  Google Scholar 

  9. Guo SW. Epigenetics of endometriosis. Mol Hum Reprod. 2009;15(10):587–607.

    Article  CAS  PubMed  Google Scholar 

  10. Lu Y, Nie J, Liu X, Zheng Y, Guo SW. Tricostatin A, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice. Hum Reprod. 2010;25(4):1014–1025.

    Article  CAS  PubMed  Google Scholar 

  11. Berkley KJ, Cason A, Jacobs H, Bradshaw H, Wood E. Vaginal hyperalgesia in a rat model of endometriosis. Neurosci Lett. 2001;306(3):185–188.

    Article  CAS  PubMed  Google Scholar 

  12. Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10(9):895–926.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Hu JY, Jin GZ. Effect of tetrahydropalmatine analogs on Fos expression induced by formalin-pain. Zhongguo Yao Li Xue Bao. 1999;20(3):193–200.

    CAS  PubMed  Google Scholar 

  14. Han YF, Hou LH, Zhou YJ, Wu XK. A survey of TCM treatment for endometriosis. J Tradit Chin Med. 2009;29(1):64–70.

    Article  PubMed  Google Scholar 

  15. Chu H, Jin G, Friedman E, Zhen X. Recent development in studies of tetrahydroprotoberberines: mechanism in antinociception and drug addiction. Cell Mol Neurobiol. 2008;28(4):491–499.

    Article  CAS  PubMed  Google Scholar 

  16. Hu JY, Jin GZ. Supraspinal D2 receptor involved in antinociception induced by l-tetrahydropalmatine. Zhongguo Yao Li Xue Bao. 1999;20(8):715–719.

    CAS  PubMed  Google Scholar 

  17. Wang GL, Zhu L. Effects of l-tetrahydropalmatine on contraction of isolated rat uterus [Zuo xuan si qing ba ma ting dui da shu li ti zi gong shou suo fan ying de ying xiang in Chinese]. Pharmacol Clin Chinese Materia Medica. 2005;21(2):14–16.

    Google Scholar 

  18. Xu JD, Wang W, Yang HX, Li ZQ, Ma LY, Hou XL. Inhibitive effect of tetrahydropalmatine on contractile activity of uterine smooth muscle strips in virginal rats [Yan Hu Suo dui wei yun da shu li ti zi gong ping hua ji yun dong de yi zhi zuo yong in Chinese]. J Clin Rehabil Tissue Eng Res. 2007;11(21):4178–4181.

    CAS  Google Scholar 

  19. Zhao GJ, Ren SL, Wu SG, et al. Effect of L-THP on contraction of blood vessels induced by 5-hydroxytryptamine (in Chinese). Chin J Pharmacol Toxicol. 1988;4:342–348.

    Google Scholar 

  20. Xing JF, et al. Effects of dl tetrahydropalmation on rabbit platelet aggregation and experimental cerebral thrombosis in rats (in Chinese). Chin Pharmacol Bull. 1997;13(3):258–10.

    CAS  Google Scholar 

  21. Gao YJ, Ji RR. c-Fos and pERK, which is a better marker for neuronal activation and central sensitization after noxious stimulation and tissue injury? Open Pain J. 2009;2:11–17.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Ikeuchi M, Kolker SJ, Burnes LA, Walder RY, Sluka KA. Role of ASIC3 in the primary and secondary hyperalgesia produced by joint inflammation in mice. Pain. 2008;137(3):662–669.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Sevcik MA, Ghilardi JR, Peters CM, et al. Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization. Pain. 2005;115(1–2):128–141.

    Article  CAS  PubMed  Google Scholar 

  24. Heppenstall PA, Lewin GR. Neurotrophins, nociceptors and pain. Curr Opin Anaesthesiol. 2000;13(5):573–576.

    Article  CAS  PubMed  Google Scholar 

  25. Binshtok AM, Wang H, Zimmermann K, et al. Nociceptors are interleukin-1beta sensors. J Neurosci. 2008;28(52):14062–14073.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Haddad JJ. On the enigma of pain and hyperalgesia: a molecular perspective. Biochem Biophys Res Commun. 2007;353(2):217–224.

    Article  CAS  PubMed  Google Scholar 

  27. Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci USA. 1989;86(7):2336–2340.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Le Bars D, Gozariu M, Cadden SW. Animal models of nociception. Pharmacol Rev. 2001;53(4):597–652.

    PubMed  Google Scholar 

  29. Bannon AW, Malmberg AB. Models of nociception: hot-plate, tail-flick, and formalin tests in rodents. Curr Protoc Neurosci. 2007;Chapter 8:Unit 8.9.

  30. Chaban VV. Visceral sensory neurons that innervate both uterus and colon express nociceptive TRPv1 and P2X3 receptors in rats. Ethn Dis. 2008;18(2 suppl 2):S2–20–4.

    PubMed  Google Scholar 

  31. Inhaka R, Gentleman RR. R: a language for data analysis and graphics. J Comput Graph Statist. 1996;5:1923–1927.

    Google Scholar 

  32. Cui L, Wu T. [L-Tetrahydropalmatine enhances inhibition of cellular proliferation by Vincristine Sulfate in human leukemia cell lines]. Chin Pharmacol Bull. 1995;11(4):348.

    Google Scholar 

  33. Lagadec C, Meignan S, Adriaenssens E, et al. TrkA overexpression enhances growth and metastasis of breast cancer cells. Oncogene. 2009;28(18):1960–1970.

    Article  CAS  PubMed  Google Scholar 

  34. Kawanami Y, Morimoto Y, Kim H, et al. Calcitonin gene-related peptide stimulates proliferation of alveolar epithelial cells. Respir Res. 2009;10:8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  35. Ribatti D, Nico B, Perra MT, et al. Correlation between NGF/TrkA and microvascular density in human pterygium. Int J Exp Pathol. 2009;90(6):615–620.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Okajima K, Harada N. Promotion of insulin-like growth factor-I production by sensory neuron stimulation; molecular mechanism(s) and therapeutic implications. Curr Med Chem. 2008;15(29):3095–3112.

    Article  CAS  PubMed  Google Scholar 

  37. Woolf CJ, Thompson SW. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain. 1991;44(3):293–299.

    Article  CAS  PubMed  Google Scholar 

  38. Sun RQ, Lawand NB, Willis WD. The role of calcitonin gene-related peptide (CGRP) in the generation and maintenance of mechanical allodynia and hyperalgesia in rats after intradermal injection of capsaicin. Pain. 2003;104(1–2):201–208.

    Article  CAS  PubMed  Google Scholar 

  39. McMahon SB. NGF as a mediator of inflammatory pain. Philos Trans R Soc Lond B Biol Sci. 1996;351(1338):431–440.

    Article  CAS  PubMed  Google Scholar 

  40. Basselin M, Chang L, Chen M, Bell JM, Rapoport SI. Chronic administration of valproic acid reduces brain NMDA signaling via arachidonic acid in unanesthetized rats. Neurochem Res. 2008;33(11):2229–2240.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Tong C, Ma W, Shin SW, James RL, Eisenach JC. Uterine cervical distension induces cFos expression in deep dorsal horn neurons of the rat spinal cord. Anesthesiology. 2003;99(1):205–211.

    Article  CAS  PubMed  Google Scholar 

  42. Stratton P, Sinaii N, Segars J, et al. Return of chronic pelvic pain from endometriosis after raloxifene treatment: a randomized controlled trial. Obstet Gynecol. 2008;111(1):88–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Ashburner BP, Westerheide SD, Baldwin AS Jr. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol. 2001;21(20):7065–7077.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Kaler P, et al. HDAC2 deficiency sensitizes colon cancer cells to TNFalpha-induced apoptosis through inhibition of NF-kappaB activity. Exp Cell Res. 2008;314(7):1507–1518.

    Article  CAS  PubMed  Google Scholar 

  45. Ma W, Bisby MA. Increased activation of nuclear factor kappa B in rat lumbar dorsal root ganglion neurons following partial sciatic nerve injuries. Brain Res. 1998;797(2):243–254.

    Article  CAS  PubMed  Google Scholar 

  46. Niederberger E, Geisslinger G. The IKK-NF-kappaB pathway: a source for novel molecular drug targets in pain therapy? Faseb J. 2008;22(10):3432–3442.

    Article  CAS  PubMed  Google Scholar 

  47. Mattson MP, Camandola S. NF-kappaB in neuronal plasticity and neurodegenerative disorders. J Clin Invest. 2001;107(3):247–254.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Chiechio S, Zammataro M, Morales ME, et al. Epigenetic modulation of mGlu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain. Mol Pharmacol. 2009;75(5):1014–1020.

    Article  CAS  PubMed  Google Scholar 

  49. Hrzenjak A, Moinfar F, Kremser ML, et al. Valproate inhibition of histone deacetylase 2 affects differentiation and decreases proliferation of endometrial stromal sarcoma cells. Mol Cancer Ther. 2006;5(9):2203–2210.

    Article  CAS  PubMed  Google Scholar 

  50. Wu Y, Starzinsky-Powitz A, Guo SW. Constitutive and TNFα-stimulated activation of nuclear factor κB (NF-κB) in immortalized endometriotic cells and their suppression by trichostatin A (TSA). Gynecol Obstet Invest. 2010;In press.

  51. Toth CC, Willis D, Twiss JL, et al. Locally synthesized calcitonin gene-related Peptide has a critical role in peripheral nerve regeneration. J Neuropathol Exp Neurol. 2009;68(3):326–337.

    Article  CAS  PubMed  Google Scholar 

  52. Tokushige N, Markham R, Russell P, Fraser IS. High density of small nerve fibres in the functional layer of the endometrium in women with endometriosis. Hum Reprod. 2006;21(3):782–787.

    Article  CAS  PubMed  Google Scholar 

  53. Zhang X, Lu B, Huang X, Xu H, Zhou C, Lin J. Endometrial nerve fibers in women with endometriosis, adenomyosis, and uterine fibroids. Fertil Steril. 2009;92(5):1799–1801.

    Article  PubMed  Google Scholar 

  54. Xu JD, Wang W, Yang HX, Li ZQ, Ma LY, Hou XL. Inhibitive effect of tetrahydropalmatine on contractile activity of uterine smooth muscle strips in virginal rats (in Chinese). J Clin Rehabil Tissue Eng Res. 2007;11(21):4178–4181.

    CAS  Google Scholar 

  55. Moynihan AT, Hehir MP, Sharkey AM, Robson SC, Europe-Finner GN, Morrison JJ. Histone deacetylase inhibitors and a functional potent inhibitory effect on human uterine contractility. Am J Obstet Gynecol. 2008;199(2):167.e1–167.e7.

    Article  CAS  Google Scholar 

  56. Novella-Maestre E, Carda C, Noguera I, et al. Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis. Hum Reprod. 2009;24(5):1025–1035.

    Article  CAS  PubMed  Google Scholar 

  57. Novella-Maestre E, et al. Identification and quantification of dopamine receptor 2 in human eutopic and ectopic endometrium: a novel molecular target for endometriosis therapy. Biol Reprod. 2010. [Epub ahead of print].

  58. Ren Y. Intramuscular injuction of Rotundine cause serious allergic reactions in 2 cases [Ji Zhu lu tong ding zhi yan zhong guo min fan ying 2 li in Chinese]. Hai nan Medicine. 2001;4:41.

    Google Scholar 

  59. Tunnicliff G. Actions of sodium valproate on the central nervous system. J Physiol Pharmacol. 1999;50(3):347–365.

    CAS  PubMed  Google Scholar 

  60. Johannessen CU. Mechanisms of action of valproate: a commentatory. Neurochem Int. 2000;37(2–3):103–110.

    Article  CAS  PubMed  Google Scholar 

  61. Jentink J, Loane MA, Dolk H, et al. Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med. 2010;362(23):2185–2193.

    Article  CAS  PubMed  Google Scholar 

  62. Liu X, Yuan L, Guo SW. Valproic acid as a therapy for adenomyosis: a comparative case series. Reprod Sci. 2010;[Epub ahead of print]

  63. Zhang JF, et al. [Determination of Rotundine in human plasma by HPLC and pharmacokinetic studies] in Chinese. J. China Pharmaceutical Univ., 1998. 29(1): p. 67–70.

    CAS  Google Scholar 

  64. Moyer TP. Therapeutic drug monitoring. In: Burtic AC, Ashwood ER, eds. Tietz Textbook of Clinical Chemistry. Philadelphia: WB Sanders; 1999:873, 876–877.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Shanghai Obstetrics and Gynecology Hospital, Fudan University Shanghai College of Medicine, 419 Fangxie Road, Shanghai, 200011, China

    Ting Zhao MD, Xishi Liu MD, PhD & Sun-Wei Guo PhD

  2. Stake Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

    Xuechu Zhen PhD

Authors
  1. Ting Zhao MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xishi Liu MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xuechu Zhen PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sun-Wei Guo PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sun-Wei Guo PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhao, T., Liu, X., Zhen, X. et al. Levo-Tetrahydropalmatine Retards the Growth of Ectopic Endometrial Implants and Alleviates Generalized Hyperalgesia in Experimentally Induced Endometriosis in Rats. Reprod. Sci. 18, 28–45 (2011). https://doi.org/10.1177/1933719110381928

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719110381928

Keywords

Search

Navigation